Use of antiretroviral therapy during pregnancy among HIV‐infected women attending an urban care centre (Englisch)
Freier Zugriff
- Neue Suche nach: Ssewankambo, F
- Neue Suche nach: Nalugwa, C
- Neue Suche nach: Sempa, J
- Neue Suche nach: Walusimbi, J
- Neue Suche nach: Kambugu, A
- Neue Suche nach: Ssewankambo, F
- Neue Suche nach: Nalugwa, C
- Neue Suche nach: Sempa, J
- Neue Suche nach: Walusimbi, J
- Neue Suche nach: Kambugu, A
In:
Journal of the International AIDS Society
;
13
;
P161
;
2010
-
ISSN:
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Use of antiretroviral therapy during pregnancy among HIV‐infected women attending an urban care centre
-
Beteiligte:Ssewankambo, F ( Autor:in ) / Nalugwa, C ( Autor:in ) / Sempa, J ( Autor:in ) / Walusimbi, J ( Autor:in ) / Kambugu, A ( Autor:in )
-
Erschienen in:Journal of the International AIDS Society ; 13 ; P161
-
Verlag:
- Neue Suche nach: The International AIDS Society
-
Erscheinungsdatum:01.11.2010
-
Format / Umfang:1 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Datenquelle:
Inhaltsverzeichnis – Band 13
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Highly active antiretroviral treatment for the prevention of HIV transmissionGranich, Reuben / Crowley, Siobhan / Vitoria, Marco / Lo, Ying‐Ru / Souteyrand, Yves / Dye, Christopher / Gilks, Charlie / Guerma, Teguest / De Cock, Kevin M / Williams, Brian et al. | 2010
- 2
-
HIV‐related restrictions on entry, residence and stay in the WHO European Region: a surveyLazarus, Jeffrey V / Curth, Nadja / Weait, Matthew / Matic, Srdan et al. | 2010
- 3
-
Integration of HIV/AIDS services into African primary health care: lessons learned for health system strengthening in Mozambique ‐ a case studyPfeiffer, James / Montoya, Pablo / Baptista, Alberto J / Karagianis, Marina / Pugas, Marilia de Morais / Micek, Mark / Johnson, Wendy / Sherr, Kenneth / Gimbel, Sarah / Baird, Shelagh et al. | 2010
- 4
-
Impact of HIV‐1 viral subtype on disease progression and response to antiretroviral therapyEasterbrook, Philippa J / Smith, Mel / Mullen, Jane / O'Shea, Siobhan / Chrystie, Ian / de Ruiter, Annemiek / Tatt, Iain D / Geretti, Anna Maria / Zuckerman, Mark et al. | 2010
- 5
-
Sexual vulnerability and HIV seroprevalence among the deaf and hearing impaired in CameroonTouko, Adonis / Mboua, Célestin P / Tohmuntain, Peter M / Perrot, Anne B et al. | 2010
- 6
-
Gender and sexuality: emerging perspectives from the heterosexual epidemic in South Africa and implications for HIV risk and preventionJewkes, Rachel / Morrell, Robert et al. | 2010
- 7
-
Are Nepali students at risk of HIV? A cross‐sectional study of condom use at first sexual intercourse among college students in KathmanduAdhikari, Ramesh et al. | 2010
- 8
-
Barriers to initiation of antiretroviral treatment in rural and urban areas of Zambia: a cross‐sectional study of cost, stigma, and perceptions about ARTFox, Matthew P / Mazimba, Arthur / Seidenberg, Phil / Crooks, Denise / Sikateyo, Bornwell / Rosen, Sydney et al. | 2010
- 9
-
Challenges faced by health workers in providing counselling services to HIV‐positive children in Uganda: a descriptive studyRujumba, Joseph / Mbasaalaki‐Mwaka, Cissy L / Ndeezi, Grace et al. | 2010
- 10
-
Couples' voluntary counselling and testing and nevirapine use in antenatal clinics in two African capitals: a prospective cohort studyConkling, Martha / Shutes, Erin L / Karita, Etienne / Chomba, Elwyn / Tichacek, Amanda / Sinkala, Moses / Vwalika, Bellington / Iwanowski, Melissa / Allen, Susan A et al. | 2010
- 11
-
High survival and treatment success sustained after two and three years of first‐line ART for children in CambodiaIsaakidis, Petros / Raguenaud, Marie‐Eve / Te, Vantha / Tray, Chhraing S / Akao, Kazumi / Kumar, Varun / Ngin, Sopheak / Nerrienet, Eric / Zachariah, Rony et al. | 2010
- 12
-
Elevated osteoprotegerin is associated with abnormal ankle brachial indices in patients infected with HIV: a cross‐sectional studyJang, James J / Schwarcz, Aron I / Amaez, Daniel A / Woodward, Mark / Olin, Jeffrey W / Keller, Marla J / Schecter, Alison D et al. | 2010
- 13
-
Sex frequency and sex planning among men who have sex with men in Bangkok, Thailand: implications for pre‐ and post‐exposure prophylaxis against HIV infectionvan Griensven, Frits / Thienkrua, Warunee / Sukwicha, Wichuda / Wimonsate, Wipas / Chaikummao, Supaporn / Varangrat, Anchalee / Mock, Philip A et al. | 2010
- 14
-
Estimating the cost of care giving on caregivers for people living with HIV and AIDS in Botswana: a cross‐sectional studyAma, Njoku O / Seloilwe, Esther S et al. | 2010
- 15
-
Neurocognitive impairment among HIV‐positive individuals in Botswana: a pilot studyLawler, Kathy / Mosepele, Mosepele / Ratcliffe, Sarah / Seloilwe, Esther / Steele, Katherine / Nthobatsang, Rudo / Steenhoff, Andrew et al. | 2010
- 16
-
An HIV epidemic is ready to emerge in the PhilippinesFarr, Anna C / Wilson, David P et al. | 2010
- 17
-
Kidney function of HIV‐infected children in Lagos, Nigeria: using Filler's serum cystatin C‐based formulaEsezobor, Christopher I / Iroha, Edna / Oladipo, Olajumoke / Onifade, Elizabeth / Soriyan, Oyetunji O / Akinsulie, Adebola O / Temiye, Edamisan O / Ezeaka, Chinyere et al. | 2010
- 18
-
Effect of multiple micronutrient supplementation on survival of HIV‐infected children in Uganda: a randomized, controlled trialNdeezi, Grace / Tylleskär, Thorkild / Ndugwa, Christopher M / Tumwine, James K et al. | 2010
- 19
-
From project aid to sustainable HIV services: a case study from ZambiaTorpey, Kwasi / Mwenda, Lona / Thompson, Catherine / Wamuwi, Edgar / van Damme, Wim et al. | 2010
- 20
-
The experiences of people living with HIV/AIDS and of their direct informal caregivers in a resource‐poor settingMajumdar, Basanti / Mazaleni, Nomathemba et al. | 2010
- 21
-
Is there an association between PEPFAR funding and improvement in national health indicators in Africa? A retrospective studyDuber, Herbert C / Coates, Thomas J / Szekeras, Greg / Kaji, Amy H / Lewis, Roger J et al. | 2010
- 22
-
Perceptions of rewards among volunteer caregivers of people living with AIDS working in faith‐based organizations in South Africa: a qualitative studyAkintola, Olagoke et al. | 2010
- 23
-
AIDS‐associated Kaposi's sarcoma is linked to advanced disease and high mortality in a primary care HIV programme in South AfricaChu, Kathryn M / Mahlangeni, Gcina / Swannet, Sarah / Ford, Nathan P / Boulle, Andrew / Van Cutsem, Gilles et al. | 2010
- 24
-
Planning for pre‐exposure prophylaxis to prevent HIV transmission: challenges and opportunitiesKim, Susan C / Becker, Stephen / Dieffenbach, Carl / Hanewall, Blair S / Hankins, Catherine / Lo, Ying‐Ru / Mellors, John W / O'Reilly, Kevin / Paxton, Lynn / Roffenbender, Jason S et al. | 2010
- 25
-
Low cholesterol? Don't brag yet … hypocholesterolemia blunts HAART effectiveness: a longitudinal studyMíguez, María Jose / Lewis, John E / Bryant, Vaughn E / Rosenberg, Rhonda / Burbano, Ximena / Fishman, Joel / Asthana, Deshratn / Duan, Rui / Madhavan, Nair / Malow, Robert M et al. | 2010
- 26
-
Linking sexual and reproductive health and HIV interventions: a systematic reviewKennedy, Caitlin E / Spaulding, Alicen B / Brickley, Deborah Bain / Almers, Lucy / Mirjahangir, Joy / Packel, Laura / Kennedy, Gail E / Mbizvo, Michael / Collins, Lynn / Osborne, Kevin et al. | 2010
- 27
-
Experiences of stigma in healthcare settings among adults living with HIV in the Islamic Republic of IranRahmati‐Najarkolaei, Fatemeh / Niknami, Shamsaddin / Aminshokravi, Farkhondeh / Bazargan, Mohsen / Ahmadi, Fazlollah / Hadjizadeh, Ebrahim / Tavafian, Sedigheh S et al. | 2010
- 28
-
Immunological response to highly active antiretroviral therapy following treatment for prevention of mother to child transmission of HIV‐1: a study in Côte d'IvoireEkouevi, Didier K / Coffie, Patrick A / Chaix, Marie‐Laure / Tonwe‐Gold, Besigin / Amani‐Bosse, Clarisse / Leroy, Valériane / Abrams, Elaine J / Dabis, François et al. | 2010
- 29
-
High rate of loss to clinical follow up among African HIV‐infected patients attending a London clinic: a retrospective analysis of a clinical cohortGerver, Sarah M / Chadborn, Tim R / Ibrahim, Fowzia / Vatsa, Bela / Delpech, Valerie C / Easterbrook, Philippa J et al. | 2010
- 30
-
An acceptability and safety study of the Duet® cervical barrier and gel delivery system in ZimbabweMontgomery, Elizabeth T / Woodsong, Cynthia / Musara, Petina / Cheng, Helen / Chipato, Tsungai / Moench, Thomas R / Spielberg, Freya / van der Straten, Ariane et al. | 2010
- 31
-
Discontinuation of standard first‐line antiretroviral therapy in a cohort of 1434 Malawian childrenBuck, W Chris / Kabue, Mark M / Kazembe, Peter N / Kline, Mark W et al. | 2010
- 32
-
A process evaluation of the scale up of a youth‐friendly health services initiative in northern TanzaniaRenju, Jenny / Andrew, Bahati / Nyalali, Kija / Kishamawe, Coleman / Kato, Charles / Changalucha, John / Obasi, Angela et al. | 2010
- 33
-
Association between HIV replication and serum leptin levels: an observational study of a cohort of HIV‐1‐infected South African womenAzzoni, Livio / Crowther, Nigel J / Firnhaber, Cynthia / Foulkes, Andrea S / Yin, Xiangfan / Glencross, Deborah / Gross, Robert / Kaplan, Mitch D / Papasavvas, Emmanouil / Schulze, Doreen et al. | 2010
- 34
-
Concurrent sexual partnerships do not explain the HIV epidemics in Africa: a systematic review of the evidenceSawers, Larry / Stillwaggon, Eileen et al. | 2010
- 35
-
A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countriesWaning, Brenda / Diedrichsen, Ellen / Moon, Suerie et al. | 2010
- 36
-
Mothers' knowledge and utilization of prevention of mother to child transmission services in northern TanzaniaFalnes, Eli Fjeld / Tylleskär, Thorkild / de Paoli, Marina Manuela / Manongi, Rachel / Engebretsen, Ingunn MS et al. | 2010
- 37
-
Barriers to accessing highly active antiretroviral therapy by HIV‐positive women attending an antenatal clinic in a regional hospital in western UgandaDuff, Putu / Kipp, Walter / Wild, T Cameron / Rubaale, Tom / Okech‐Ojony, Joa et al. | 2010
- 38
-
Factors associated with access to HIV care and treatment in a prevention of mother to child transmission programme in urban ZimbabweMuchedzi, Auxilia / Chandisarewa, Winfreda / Keatinge, Jo / Stranix‐Chibanda, Lynda / Woelk, Godfrey / Mbizvo, Elizabeth / Shetty, Avinash K et al. | 2010
- 39
-
Change in condom and other barrier method use during and after an HIV prevention trial in Zimbabwevan der Straten, Ariane / Cheng, Helen / Minnis, Alexandra M et al. | 2010
- 40
-
New diagnostics for tuberculosis: fulfilling patient needs firstLemaire, Jean‐François / Casenghi, Martina et al. | 2010
- 41
-
Targeting the hotspots: investigating spatial and demographic variations in HIV infection in small communities in South AfricaWand, Handan / Ramjee, Gita et al. | 2010
- 42
-
Baseline severe anaemia should not preclude use of zidovudine in antiretroviral‐eligible patients in resource‐limited settingsKiragga, Agnes N / Castelnuovo, Barbara / Nakanjako, Damalie / Manabe, Yukari C et al. | 2010
- 43
-
Cost analysis of centralized viral load testing for antiretroviral therapy monitoring in Nicaragua, a low‐HIV prevalence, low‐resource settingGerlach, Jay / Sequeira, Magda / Alvarado, Vivian / Cerpas, Christian / Balmaseda, Angel / Gonzalez, Alcides / de los Santos, Tala / Levin, Carol E / Amador, Juan Jose / Domingo, Gonzalo J et al. | 2010
- 44
-
Associations between depressive symptoms, sexual behaviour and relationship characteristics: a prospective cohort study of young women and men in the Eastern Cape, South AfricaNduna, Mzikazi / Jewkes, Rachel K / Dunkle, Kristin L / Shai, Nwabisa P Jama / Colman, Ian et al. | 2010
- 45
-
Sexual behaviour does not reflect HIV‐1 prevalence differences: a comparison study of Zimbabwe and TanzaniaMapingure, Munyaradzi P / Msuya, Sia / Kurewa, Nyaradzai E / Munjoma, Marshal W / Sam, Noel / Chirenje, Mike Z / Rusakaniko, Simbarashe / Saugstad, Letten F / de Vlas, Sake J / Stray‐Pedersen, Babill et al. | 2010
- 46
-
Increased vulnerability of rural children on antiretroviral therapy attending public health facilities in South Africa: a retrospective cohort studyFatti, Geoffrey / Bock, Peter / Grimwood, Ashraf / Eley, Brian et al. | 2010
- 47
-
The history of AIDS exceptionalismSmith, Julia H / Whiteside, Alan et al. | 2010
- 48
-
Experiencing antiretroviral adherence: helping healthcare staff better understand adherence to paediatric antiretroviralsPhelps, Benjamin R / Hathcock, Sarah J / Werdenberg, Jennifer / Schutze, Gordon E et al. | 2010
- 49
-
The importance of clinic attendance in the first six months on antiretroviral treatment: a retrospective analysis at a large public sector HIV clinic in South AfricaBrennan, Alana T / Maskew, Mhairi / Sanne, Ian / Fox, Matthew P et al. | 2010
- 50
-
Experiences of women who have lost young children to AIDS in KwaZulu‐Natal, South Africa: a qualitative studyDemmer, Craig et al. | 2010
- 51
-
Cancers in the TREAT Asia HIV Observational Database (TAHOD): a retrospective analysis of risk factorsPetoumenos, Kathy / Hui, Eugenie / Kumarasamy, Nagalingeswaran / Kerr, Stephen J / Choi, Jun Yong / Chen, Yi‐Ming A / Merati, Tuti / Zhang, Fujie / Lim, Poh‐Lian / Sungkanuparph, Somnuek et al. | 2010
- 52
-
Attitudes to routine HIV counselling and testing, and knowledge about prevention of mother to child transmission of HIV in eastern Uganda: a cross‐sectional survey among antenatal attendeesByamugisha, Robert / Tumwine, James K / Ndeezi, Grace / Karamagi, Charles AS / Tylleskär, Thorkild et al. | 2010
- I1
-
Visioning services for children affected by HIV and AIDS through a family lensRichter, Linda / Beyrer, Chris / Kippax, Susan / Heidari, Shirin et al. | 2010
- I1
-
Workshop report: “Towards a Cure: HIV Reservoirs and Strategies to Control Them”Jefferys, Richard J et al. | 2010
- K1
-
Why suppression of HIV replication does not always make everything betterLederman, M et al. | 2010
- K2
-
The public health implications of antiretroviral therapy – 2011 and beyondDe Cock, KM et al. | 2010
- K3
-
ART achievements and challenges in AfricaHakim, J et al. | 2010
- O1
-
CD4+ T cell reconstitution, T cell activation, and memory T cell subset composition in blood and gut of HIV‐negative and ART‐suppressed HIV‐positive patients: implications for HIV persistence in the gutYukl, S / Sinclair, E / Epling, L / Li, Q / Shergill, A / McQuaid, K / Duan, L / Hare, B / Lampiris, H / Haase, A et al. | 2010
- O1
-
The changing face of HIV resistance; HIV drug resistance north and south — what's next?Schapiro, J et al. | 2010
- O2
-
International perspectives on adherence and resistance to HIV antiretroviral therapyBangsberg, D et al. | 2010
- O2
-
Most HIV DNA in PBMC is present in non‐gut homing, resting memory CD4+ T cells with a ß7‐CD38‐CD127 high phenotypeKoelsch, KK / Xu, Y / Bailey, M / McBride, K / Seddiki, N / Suzuki, K / Murray, J / Cooper, DA / Kelleher, AD / Zaunders, J et al. | 2010
- O3
-
Where are macrophage‐tropic viruses?Schnell, G / Joseph, S / Spudich, S / Price, R / Swanstrom, R et al. | 2010
- O3
-
Adherence to antiretroviral treatment regimens and correlation with risk of hospitalization among commercially insured HIV patients in the USSax, PE / Meyers, JL / Mugavero, MJ / Davis, KL et al. | 2010
- O4
-
Novel pathways of transcriptional and post‐transcriptional regulation of post‐integrative HIV‐1 latencyMarcello, A / Kula, A / Dieudonne, M / Knezevich, A / Maiuri, P et al. | 2010
- O4
-
Long‐term probability of detecting drug‐resistant HIV in patients starting antiretroviral therapy within the first year of HIV infectionLodi, S / Kücherer, C / Kran, AM Bakken / Masquelier, B / Monforte, A d'Arminio / Gill, J / Dunn, D / Pillay, D / Porter, K et al. | 2010
- O5
-
Low‐level residual viremia and risk of virological failureCologni, G / Soavi, L / Leone, S / Valenti, D / Callegaro, A / Gregis, G / Suter, F / Maggiolo, F et al. | 2010
- O5
-
HIV‐1 Tat complexes reveal subunit composition of active P‐TEFb and stable association with 7SKsnRNPSobhian, B / Laguette, N / Yatim, A / Nakamura, M / Levy, Y / Kiernan, R / Benkirane, M et al. | 2010
- O6
-
The EuResist expert model for customised HAART optimisation: 2010 update and extension to newest compoundsPironti, A / Sönnerborg, A / Zazzi, M / Kaiser, R / Struck, D / Clotet, B / Vandamme, ÀM / Incardona, F / Lengauer, T / Rosen‐Zvi, M et al. | 2010
- O6
-
Homeostatic proliferation of memory T cells and expansion of the HIV‐1 latent reservoirBosque, A / Planelles, V et al. | 2010
- O7
-
Myeloid dendritic cells induce HIV‐1 latency in non‐proliferating CD4+ T cellsEvans, VA / Saleh, S / Haddad, EK / Cameron, PU / Sekaly, R‐P / Lewin, SR et al. | 2010
- O7
-
Consensus statement of the European guidelines on clinical management of HIV‐1 tropism testingVandekerckhove, LPR / Wensing, AMJ / Kaiser, R / Brun‐Vezinet, F / Clotet, B / De Luca, A / Dressler, S / Garcia, F / Geretti, AM / Klimkait, T et al. | 2010
- O8
-
Calibration and accuracy of the geno2pheno co‐receptor algorithm for predicting HIV tropism for single and triplicate measurements of V3 genotypeSwenson, LC / Knapp, D / Harrigan, PR et al. | 2010
- O8
-
Tetherin restricts direct cell‐cell viral transfer and transmission of HIV‐1Kuhl, BD / Sloan, RD / Donahue, DA / Bar‐Magen, T / Liang, C / Wainberg, MA et al. | 2010
- O9
-
Short‐term variation of HIV tropism readouts in the absence of CCR5 antagonistsBrumme, CJ / Dong, W / Chan, D / Mo, T / Swenson, LC / Woods, C / Demarest, J / Heera, J / Valdez, H / Harrigan, PR et al. | 2010
- O9
-
The role of the ubiquitin‐proteasome pathway in rhTRIM5α restriction of HIV‐1Danielson, CM / Hope, TJ et al. | 2010
- O10
-
Impact of baseline HIV‐1 tropism on viral response and CD4 gains in antiretroviral‐naïve patientsSeclén, E / Gonzalez, M / Martín‐Carbonero, L / Gellermann, H / Cairns, V / Distel, M / Kadus, W / Soriano, V / Poveda, E et al. | 2010
- O10
-
LEDGF/p75 is critical but not essential for multiple‐round HIV 1 replicationSchrijvers, RLG / De Rijck, J / Gijsbers, R / Ronen, K / Bushman, FD / Debyser, Z et al. | 2010
- O11
-
Changes in CD4+ cells’ miRNA expression following exposure to HIV‐1Bignami, F / Pilotti, E / Bertoncelli, L / Ronzi, P / Gulli, M / Marmiroli, N / Magnani, G / Pinti, M / Mussini, C / Lopalco, L et al. | 2010
- O11
-
Influence of amount and percentage of CXCR4‐using virus in predicting week 48 responses to maraviroc in treatment‐naïve patientsValdez, H / Chapman, D / Biswai, P / Lewis, M / Craig, C / Heera, J / Ellery, S / Swenson, LC / Harrigan, PR et al. | 2010
- O12
-
Treatment as prevention within the framework of current guidelinesMontaner, J et al. | 2010
- O12
-
Impact of Raltegravir on immune reconstitution and thymopoiesis in HIV‐1‐infected patients with undetectable viremiaGarrido, C / Rallón, N / Zahonero, N / de la O López, M / Soriano, V / de Mendoza, C / Benito, JM et al. | 2010
- O13
-
Treatment‐as‐prevention: stopping the epidemic of HIVWilliams, B et al. | 2010
- O13
-
Effect of 24 weeks of intensification with a CCR5‐antagonist on the decay of the HIV‐1 latent reservoirDíaz, L / Gutiérrez, C / Page, C / Lorente, R / Hernández‐Novoa, B / Vallejo, A / Domínguez, E / Abad, M / Madrid, N / Moreno, A et al. | 2010
- O14
-
Epigenetic drug Gar1041 in combination with antiretroviral therapy transiently reduces the proviral DNA reservoir in SIVmac251‐infected macaquesLewis, MG / Norelli, S / Chomont, N / De Fonseca, S / Sgarbanti, M / Collins, M / Chirullo, B / Yalley‐Ogunro, J / Greenhouse, J / Palamara, AT et al. | 2010
- O14
-
Test and treat — community perspectivesSpire, B et al. | 2010
- O15
-
Purging the HIV‐1 reservoir through the disruption of the PD‐1 pathwayDaFonseca, S / Chomont, N / El Far, M / Boulassel, R / Routy, J / Sékaly, R et al. | 2010
- O15
-
HIV treatment as prevention — human rights issuesAmon, J et al. | 2010
- O16
-
Measurements of total and integrated HIV DNA demonstrate sporadic blips of unintegrated HIV DNA in HIV‐positive patients on HAARTMexas, A / Graf, E / Agosto, L / Yu, JJ / Pace, M / Liszewski, M / Migueles, S / Connors, M / O’Doherty, U et al. | 2010
- O16
-
A pilot study to determine the prevalence of HIV in persons presenting for care with selected conditions: preliminary results from the HIV in Europe studySönnerborg, A / Mocroft, A / Lundgren, JD / Raben, D / Gatell, J / Vassilenko, A / Hadziosmanovic, V / Bergovac, J / Sørensen, H / Cusini, M et al. | 2010
- O17
-
The state of PI monotherapy and NRTI‐sparing therapyArribas, JR et al. | 2010
- O18
-
Ritonavir‐boosted protease inhibitor monotherapy is 6% less effective than combination antiretroviral therapy in a meta‐analysisBierman, WFW / Humphreys, EH / van Agtmael, MA / Boucher, CA / Rutherford, GW et al. | 2010
- O19
-
Low‐level viraemia during treatment with darunavir/r monotherapy versus DRV/r + 2NRTIs in the MONET trialClumeck, N / Arribas, JR / Pulick, P / Fätkenheuer, G / Hill, A / Van Delft, Y / Moecklinghoff, C et al. | 2010
- O20
-
Virological findings from the SARA trial: boosted PI monotherapy as maintenance second‐line ART in AfricaPillay, D / Goodall, R / Gilks, CF / Yirrell, D / Gibb, D / Spyer, M / Kaleebu, P / Munderi, P / Kityo, C / McCormick, A et al. | 2010
- O21
-
Virological outcomes in ARV‐naïve patients switching or not from a first successful boosted PI‐regimen to efavirenz, nevirapine or abacavir regimensBommenel, T / Meynard, JL / Launay, O / Simon, A / Mahamat, A / Martinez, V / Gilquin, J / Katlama, C / Lascaux, AS / Pradier, C et al. | 2010
- O22
-
The clinical development of NRTIs — cautionary talesCooper, D et al. | 2010
- O23
-
Major issues and their solutions in the management of HIV and TB — from the laboratory to the patient and populationSchechter, M et al. | 2010
- O24
-
Population pharmacokinetics of lopinavir and ritonavir in combination with rifampicin‐based antitubercular treatment in HIV‐infected childrenZhang, C / Denti, P / Simonsson, USH / Maartens, G / Karlsson, MO / McIlleron, H et al. | 2010
- O25
-
Growing old with HIV — dealing with co‐morbiditiesPowderly, W et al. | 2010
- O26
-
HIV therapy in an ageing population — the challenge of polypharmacyBack, DJ et al. | 2010
- O27
-
Impact on life expectancy of late diagnosis and treatment of HIV‐1 infected individuals: UK CHICMay, MT / Gompels, M / Sabin, CA et al. | 2010
- O28
-
Mitochondrial ageing and antiretroviral therapy exposurePayne, BAI / Hateley, CA / Samuels, DC / Wilson, IJ / Santibanez‐Koref, M / Price, DA / Chinnery, PF et al. | 2010
- O29
-
Hepatitis C new drugsWedemeyer, H et al. | 2010
- O30
-
Host genetics of HCV disease — IL28BFellay, J et al. | 2010
- O31
-
Hepatitis C — feedback from the Consensus Conference on the Management of Acute Hepatitis C (AHC) in Paris, May 2010Vogel, M et al. | 2010
- O32
-
Efficacy and safety of peginterferon alfa‐2a + RBV in cHCV/HIV‐ vs cHCV‐infected patients: interim analysis of a multicenter German cohortBaumgarten, A / Lutz, T / Kreckel, P / Wellmann, E / Alshuth, U / Mauss, S / Rockstroh, J et al. | 2010
- O33
-
The pharmacokinetic and safety profile of raltegravir and ribavirin, when dosed separately and together, in healthy volunteersAshby, J / Garvey, LJ / Erlwein, OW / Lamba, H / Weston, R / Legg, K / McClure, MO / Dickinson, L / D'Avolio, A / Back, DJ et al. | 2010
- O34
-
How early to start: what do observational data suggest?Sterne, J et al. | 2010
- O35
-
HIV/HAART and the brain — what's going on?Portegies, P et al. | 2010
- O36
-
Adolescents with perinatally acquired HIV — coming your wayFoster, C et al. | 2010
- O37
-
Early mortality following ART initiation in HIV‐infected adults and children in Uganda and ZimbabweWalker, AS / Mugyenyi, P / Munderi, P / Hakim, J / Kekitiinwa, AA / Katabira, E / Gilks, CF / Kityo, C / Nahirya‐Ntege, P / Nathoo, K et al. | 2010
- O38
-
Highlights of the 12th International Workshop on Adverse Drug Reactions and Co‐Morbidities in HIV, London, November 2010Schambelan, M et al. | 2010
- O39
-
Fatal and non‐fatal AIDS and non‐AIDS events in HIV‐1 infected patients with high CD4 countsReekie, J / Gatell, J / Yust, I / Bakowska, E / Rachmanova, A / Losso, M / Krasnov, M / Francioli, P / Kowalska, J / Mocroft, A et al. | 2010
- O40
-
Cardiovascular risk assessment in persons with HIV in the developing world: comparing three risk equations in a cohort of HIV‐infected ThaisEdwards‐Jackson, N / Kerr, SJ / Tieu, HV / Ananworanich, J / Hammer, SM / Ruxrungtham, K / Phanuphak, P / Avihingsanon, A et al. | 2010
- O41
-
What affects the bone in our HIV‐positive patients?Fux, CA et al. | 2010
- O42
-
Vitamin D and HIV: shine a lightCurrier, J et al. | 2010
- O43
-
Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA studyViard, JP / Souberbielle, JC / Kirk, O / Knysz, B / Losso, M / Gatell, J / Pedersen, C / Bogner, JR / Mocroft, A / Lundgren, JD et al. | 2010
- O44
-
Maraviroc intensification for HIV‐1‐positive immunological non‐responders (INRs) despite virological suppression during HAARTRusconi, S / Vitiello, P / Adorni, F / Colella, E / Focà, E / Capetti, AF / Meraviglia, P / Abeli, C / Bonora, S / D'Annunzio, M et al. | 2010
- O45
-
Maraviroc (MVC) increases CD4+ and CD8+ cells: long‐term data from the MVC clinical development programLazzarin, A / Sierra‐Madero, JG / Battegay, M / Mukwaya, G / Burnside, R / Chapman, D / McCracken, J / Portsmouth, S / Valluri, S / Valdez, H et al. | 2010
- O46
-
HIV entry blocked by maraviroc can cause an overestimation of viral loadSloan, RD / Kuhl, BD / Kramer, VG / Donahue, DA / Bar‐Magen, T / Tressler, R / Wainberg, MA et al. | 2010
- O47
-
The SENSE trial: etravirine shows lower prevalence and severity of neuropsychiatric adverse events compared to efavirenz in treatment‐naïve patientsStellbrink, HJ / Rugina, S / Zagler, C / Esser, S / Castagna, A / Gazzard, B / Hill, A / van Delft, Y / Marks, S et al. | 2010
- O48
-
Pooled week 48 safety and efficacy results from the ECHO and THRIVE phase III trials comparing TMC278 vs EFV in treatment‐naïve, HIV‐1‐infected patientsCohen, C / Molina, JM / Cahn, P / Clotet, B / Fourie, J / Grinsztejn, B / Hao, W / Johnson, M / Supparatpinyo, K / Crauwels, HM et al. | 2010
- O49
-
Lersivirine: a new NNRTI active across HIV‐1 subtypes with a unique resistance profileMori, J / Westby, M / Tawadrous, M / van der Ryst, E / Charles, C et al. | 2010
- O50
-
Once‐daily S/GSK1349572 combination therapy in antiretroviral‐naïve adults: rapid and potent 24‐week antiviral responses in SPRING‐1 (ING112276)Rockstroh, J / Felizarta, F / Maggiolo, F / Pulido, F / Stellbrink, HJ / Tsybakova, O / Yeni, P / Almond, S / Brothers, C / Song, I et al. | 2010
- O51
-
Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961)Eron, J / Livrozet, JM / Morlat, P / Lazzarin, A / Katlama, C / Hawkins, T / Fujiwara, T / Cuffe, R / Vavro, C / Santiago, J et al. | 2010
- P1
-
Health‐related quality of life and fatigue in HIV‐1 infected patients diagnosed during primary versus chronic infectionSteingrover, R / Nievaard, MAF / Lange, JMA / Nieuwkerk, PT / Prins, JM et al. | 2010
- P2
-
The management of acute retroviral syndromeHristea, A / Petre, R / Gliga, S / Olaru, I / Ion, M / Moroti, R / Popescu, C / Mihailescu, R / Radulescu, M / Arama, V et al. | 2010
- P3
-
ARTEMIS: 192‐week efficacy and safety of once‐daily darunavir/ritonavir (DRV/r) vs lopinavir/r (LPV/r) in treatment‐naïve HIV‐1‐infected adultsOrkin, C / DeJesus, E / Khanlou, H / Stoehr, A / Supparatpinyo, K / Van de Casteele, T / Lathouwers, E / Spinosa‐Guzman, S et al. | 2010
- P4
-
Nevirapine (NVP) vs ritonavir‐boosted atazanavir (ATV/r) combined with tenofovir/emtricitabine (TDF/FTC) in first‐line therapy: NEWART 48‐week dataDeJesus, E / Mills, A / Bhatti, L / Conner, C / Storfer, S et al. | 2010
- P5
-
Efficacy and safety of an NRTI‐sparing regimen in antiretroviral‐naïve HIV‐infected patients: once‐daily maraviroc plus lopinavir/ritonavirNozza, S / Galli, L / Di Pietro, M / Mazzotta, F / Canducci, F / Pogliaghi, M / Chiappetta, S / Galli, A / Rusconi, V / Salpietro, S et al. | 2010
- P6
-
5‐year safety and efficacy of the once‐daily antiretroviral regimen of efavirenz (EFV)/emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF)Lazzarin, A / Johnson, M / Ribera, E / Weitner, L / Chen, SS / Warren, DR et al. | 2010
- P7
-
SUPPORT: 48‐week results of fosamprenavir/ritonavir vs efavirenz with abacavir/lamivudine in under‐represented, antiretroviral‐naïve patientsKumar, P / DeJesus, E / Huhn, G / Sloan, L / Garcia, F / Small, C / Edelstein, H / Felizarta, F / Hao, R / Ha, B et al. | 2010
- P8
-
HRQoL improves in treatment‐naïve HIV‐1 subjects initiated on lopinavir/ritonavir (LPV/r) with raltegravir (RAL) or tenofovir/emtricitabine (TDF/FTC)Baran, RW / Dietz, B / Fredrick, LM / Tian, M / Podsadecki, T et al. | 2010
- P9
-
Outcomes in antiretroviral‐naive HIV‐infected patients initiating therapy with TDF/FTC plus either atazanavir/r or another third recommended drugBillaud, E / Lacombe, JM / Abgrall, A / Ghosn, J / Launay, O / Livrozet, JM / Meynard, JL / Pavie, J / Costagliola, D et al. | 2010
- P10
-
Comparing the effectiveness of efavirenz and nevirapine for first‐line antiretroviral treatment amongst an adult treatment cohort from South AfricaBock, P / Fatti, G / Grimwood, A et al. | 2010
- P11
-
Comparative efficacy and safety of regimens including ritonavir‐boosted lopinavir or nevirapine in antiretroviral‐naïve HIV‐1‐infected individualsPereira, A / Lopes da Cruz, JP / Carvalho, C / Gonçalves, C / Antunes, F et al. | 2010
- P12
-
Efficacy and safety of TDF/FTC‐containing, first‐line HAART in clinical practice: 3‐year data from the German outpatient cohortvan Lunzen, J / Fätkenheuer, G / Lutz, T / Klauke, S / Mauss, S / Knechten, H / Braun, P / Gallo, L / Goldbach, J et al. | 2010
- P13
-
Reasons for treatment discontinuation in the first year after beginning antiretroviral therapy in a cohort of Portuguese HIV‐infected patientsCaldas, C / Andrade, P / Azevedo, C / Piñeiro, C / Serrão, R / Soares, J / Marques, R / Sarmento, A et al. | 2010
- P14
-
Insights into antiretroviral treatment changes in previously naïve patients: results of a Portuguese cohortSilva, C / Bento, D / Rijo, J / Alfaiate, D / Aldir, I / Araújo, C / Farinha, H / Mansinho, K et al. | 2010
- P15
-
Factors associated with treatment modification during the first year of contemporary HAARTMartin, N / Perez‐Valero, I / San Jose Valiente, B / Mora, M / Bernardino‐Serna, JI / Gonzalez, J / Gaya, F / Zamora, FX / Pena, JM / Arribas, JR et al. | 2010
- P16
-
Impact of timing HAART initiation on immune status and clinical course in the cohort of the German competence network for HIV/AIDSPlettenberg, A / Brockmeyer, NH / Haastert, B / Dupke, S / Schewe, CK / Rausch, M / Hower, M / Arendt, G / Jansen, K / KompNet, HIV et al. | 2010
- P17
-
Efficient immune reconstitution in HIV+ naïve patients (pts) starting a first lopinavir/ritonavir‐containing regimen with low CD4 countsMerlini, E / Sinigaglia, E / Carpani, G / Bini, T / d'Arminio Monforte, A / Marchetti, GC et al. | 2010
- P18
-
Immunological response among patients with undetectable viral load followed for 5 yearsPiñeiro, C / Santos, AS / Cardoso, S / Nuak, J / Lucas, R / Ferreira, A / Xerinda, S / Tavares, M / Marques, R / Sarmento, A et al. | 2010
- P19
-
Epidemiological features, therapeutic strategies and long‐term immunological outcomes in virologically suppressed HIV+ very late presentersMartinelli, L / Francisci, D / Sgrelli, A / Baldelli, F et al. | 2010
- P20
-
Sex matters: retrospective data collection on the date of commencement of ART for HIV‐positive women and men in the German KompNet cohort (1991‐2009)Krznaric, I / Wienbreyer, A / Zoufaly, A / Kreckel, P / Esser, S / Harrer, T / Jansen, K / Michalik, C / Hertling, S et al. | 2010
- P21
-
Response to HAART according to sex and origin (immigrant vs autochthonous) in a cohort of patients who initiate antiretroviral treatmentPerez‐Molina, JA / Mora‐Rillo, M / Suarez‐Lozano, I / Casado, JL / Teira, R / Rivas, P / Pedrol, E / Hernando, A / Domingo, P / Barquilla, E et al. | 2010
- P22
-
Eligibility for the initiation of HIV treatment in the context of the updated EACS guidelines: results of a clinical auditAichelburg, MC / Schlag, M / Rieger, A et al. | 2010
- P23
-
Cross‐sectional study of HIV living people cohort to specify indications to antiretroviral treatment in naïve patientsPronin, AJ / Kaminskiy, GD et al. | 2010
- P24
-
Changing antiretrovirals whilst viral load <50 copies/ml and relationship with CD4 count changesMocroft, A et al. | 2010
- P25
-
Influence of demographic and disease parameters on virological response to once‐ vs twice‐daily darunavir/ritonavir (DRV/r) at week 48 in ODINSension, M / Arns Da Cunha, C / Domingo, P / Supparatpinyo, K / Van De Casteele, T / De Doncker, P / Tomaka, F et al. | 2010
- P26
-
Health‐related quality of life (HRQoL) assessment with once‐ and twice‐daily darunavir/ritonavir (DRV/r) in the ODIN trialSpinosa‐Guzman, S / Van de Casteele, T / De La Rosa, G / De Doncker, P et al. | 2010
- P27
-
Darunavir in experienced patientsSterrantino, G / Borchi, B / Trotta, M / Bartolozzi, D / Leoncini, F et al. | 2010
- P28
-
Efficacy and tolerability of darunavir/r 600/100 mg bid in treatment‐experienced patients: 48‐week data from a German outpatient cohortvan Lunzen, J / Gorriahn, D / Wünsche, T / Dupke, S / Gute, P / Schewe, CK / Ranneberg, B et al. | 2010
- P29
-
Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment‐experienced HIV‐1 patients with virological success: DARDAR studySchneider, L / Houssaini, A / Lambert, S / Peytavin, G / Agher, R / Chermak, A / Flandre, P / Calvez, V / Marcelin, AG / Ghosn, J et al. | 2010
- P30
-
Efficacy and safety of lopinavir/ritonavir (LPV/r) in antiretroviral‐experienced subjects infected with different subtypes of HIV‐1Maroldo, L / Fredrick, LM / Robinson‐Morgan, K / Trinh, R / Podsadecki, TJ et al. | 2010
- P31
-
Long‐term efficacy and safety of atazanavir/ritonavir treatment in a real‐life cohort of treatment‐experienced HIV patientsJansen, K / Sönnerborg, A / Pugliese, P / Biguenet, S / Eychenne, JL / Brockmeyer, NH / Michalik, C / Dupke, S / Jaeger, H / Plettenberg, A et al. | 2010
- P32
-
Integrase inhibitor‐based treatment in clinical practiceCenderello, G / Piscopo, R / Feasi, M / Penco, G / Bobbio, N / Cassola, G et al. | 2010
- P33
-
Switching to a ‘nuke‐sparing’ raltegravir/atazanavir combination: an individualised approachGrant, A / Kamuntu, Y / Read, P / Kulasegaram, R et al. | 2010
- P34
-
Portuguese cohort: raltegravir with optimized background therapy (OBT) in multiple‐experienced HIV1‐ and HIV2‐infected patientsDoroana, M / Piñeiro, C / Maltez, F / Fonseca, P / Oliveira, J / Mansinho, K / Horta, A / Teófilo, E / Aguas, M / Germano, I et al. | 2010
- P35
-
Reasons for using and efficacy of raltegravir in salvage regimens without protease inhibitors in clinical practiceLlibre, JM / Martínez, E / Barreiro, P / Escrig, R / Ribera, E / Cervantes, M / Imaz, A / Gutierrez, F / Knobel, H / Ornelas, A et al. | 2010
- P36
-
Use of once‐daily raltegravir‐based HAART in HIV‐infected injection drug usersTossonian, HK / Raffa, JD / Alenezi, O / Anderson, K / Jassemi, S / Wight, K / DeVlaming, S / Conway, B et al. | 2010
- P37
-
Temporal trend of the first prescription of nevirapine: the ANRS CO3 Aquitaine Cohort, 1997‐2008Bruyand, M / Geffard, S / Lawson‐Ayayi, S / Dauchy, F / Miremont‐Salamé, G / Greib, C / Farbos, S / Morlat, P / Dabis, F et al. | 2010
- P38
-
Long‐term follow‐up of HIV‐infected patients in salvage therapy with raltegravir plus optimized background regimens: a multicentre Italian experienceLandonio, S / Meraviglia, P / Capetti, AF / Di Biagio, A / Lo Caputo, S / Sterrantino, G / Ammassari, A / Menzaghi, B / Franzetti, M / De Socio, G et al. | 2010
- P39
-
Immunologic impact of maraviroc in clinical practice of a university hospitalPaniagua, S Plata / Lopez, N Trovato / Romera, I Castillo / Larisgoitia, A Ais / Cano, J Bellon / Saez, M Sanjurjo et al. | 2010
- P40
-
Short‐course intensification with enfuvirtide in virologic failure: impact on intracellular HIV reservoir and on viral tropism (INNOVE study)Ghosn, J / Delaugerre, C / Pinta, A / Pierre, N / Etienne, D / Raffi, F / Morand‐Joubert, L et al. | 2010
- P41
-
Efficacy of once daily darunavir/ritonavir 800/100 mg in PI/r‐experienced HIV‐1 infected patients with suppressed HIV‐1 replication: the RADAR studyGhosn, J / Chermak, A / Houssaini, A / Peytavin, G / Lambert‐Niclot, S / Eychenne, N / Slama, L / Brunet, A / Duvivier, C / Simon, A et al. | 2010
- P42
-
Switching to Atripla (EFV/FTC/TDF) from Kivexa (ABC/3TC) plus EFV leads to improved perceptions of treatment: results from the ROCKET 1 studyCooper, V / Horne, R / Ewan, J et al. | 2010
- P43
-
Long‐term outcomes of switching to fixed‐dose abacavir/lamivudine (ABC/3TC) or tenofovir/emtricitabine (TDF/FTC): 3‐year results of the BICOMBO studyMartínez, E / Arranz, JA / Podzamczer, D / Lonca, M / Sanz, J / Barragán, P / Knobel, H / Ribera, E / Gutierrez, F / Valero, S et al. | 2010
- P44
-
Tolerance and durability of abacavir/lamivudine (ABC/3TC)‐containing regimens: results from a large prospective French cohortCuzin, L / Allavena, C / Levy‐Bachelot, L / Valantin, MA / Mellliez, H / Pugliese, P / Poizot‐Martin, I / Duvivier, C / Finkielsztejn, L / Abel, S et al. | 2010
- P45
-
48‐week efficacy and safety of transitioning virologically stable HIV‐1 patients from nevirapine IR 200 mg BID to nevirapine XR 400 mg QD (TRANxITION)Arastéh, K / Ward, A / Plettenberg, A / Livrozet, JM / Cordes, C / Winston, A / Wang, E / Quinson, A et al. | 2010
- P46
-
Lopinavir to atazanavir or darunavir switch in HIV‐1‐infected patients with dyslipidemia: an observational studyLe Moal, G / Beraud, G / Prazuck, T / Hocqueloux, L / Dupuis, A / Venisse, N et al. | 2010
- P47
-
Switch to once or twice daily unboosted atazanavir in a cohort of stable HIV patients: strong differences in drug exposure and virological outcomeBaudry, T / Boibieux, A / Gagnieu, MC / Cotte, L / Livrozet, JM / Miahles, P / Makhloufi, D / Chidiac, C / Peyramond, D / Ferry, T et al. | 2010
- P48
-
Analysis of determinants of long‐term efficacy of unboosted atazanavir‐based regimens in the clinical settingBonora, S / Calcagno, A / Viganò, O / Bigliano, P / Rusconi, S / Trentini, L / Tettoni, MC / Orofino, G / Salassa, B / Bramato, C et al. | 2010
- P49
-
Switching from tipranavir (TPV) 500/ritonavir (RTV) 200 mg to TPV 500/RTV 100 mg in treatment‐experienced patients (pts) with HIV RNA <50 copies/mLCasado, JL / Domingo, P / Rubio, R / Antela, A / Lopez‐Ruz, MA / Castro, A / Portilla, J / Ribera, E / Podzamczer, D / Oteo, JA et al. | 2010
- P50
-
Lopinavir/ritonavir monotherapy in clinical practiceCaso, A / Valencia, E / Moreno, V / Cervero, M / Sanz, J / Torres Perea, R et al. | 2010
- P51
-
Switching to dual therapy with darunavir/ritonavir and etravirine: a simplification strategyTyrer, M / Swaden, L / Marshall, NJ / Johnson, M et al. | 2010
- P52
-
Changes in cerebral function parameters in HIV‐1 infected subjects undergoing a treatment simplification to darunavir/ritonavirGarvey, LJ / Higgs, C / Mohammed, P / Nelson, M / Winston, A et al. | 2010
- P53
-
Epidemiological description of the demographic and HIV disease characteristics of HIV patients who are in care but not on treatment in SpainDomingo, P / Arazo, P / Casado, JL / Castaño, MA / Ferrer, E / Goenaga, MA / Granados, R / Pulido, F / Rodriguez, J / Rubio, R et al. | 2010
- P54
-
Treatment of HIV‐2 infection: a retrospective study from a Portuguese centerMarques, N / Seixas, D / Crespo, P / Malcata, L / Vaz, J / Mota, V / Morais, C / Oliveira, J / Duque, V / Saraiva da Cunha, J et al. | 2010
- P55
-
The prognosis of patients with dissociated virological and immunological responses to HAARTJevtovic, DJ / Salemovic, DR / Ranin, JT et al. | 2010
- P56
-
Prediction of virological failure in HIV‐infected individuals treated with cART in SurinameBleijenberg, MP / Bierman, WFW / Jaglall, C / Heymans, MW / ten Doesschate, MC / Nieuwkerk, PT / Smits, PH / van Eer, M / Vreden, S et al. | 2010
- P57
-
British HIV and ageing study. HIV and ageing: older people with HIV, who are they?Allan, S / Daly, RA / Yoganathan, Y / Barrett, S / Joseph, A / Tariq, A / Saing, CW / Williams, C / Lane, C / Sikorska, J et al. | 2010
- P58
-
A comparison of the FDA TLOVR and FDA Snapshot algorithms based on studies evaluating once‐daily vs. twice daily lopinavir/ritonavir (LPV/r) regimensQaqish, R / van Wyk, J / King, MS et al. | 2010
- P60
-
Long‐term efficacy and safety of low‐dose ritonavir‐boosted atazanavir (ATV/r) 200/100 mg in HIV‐infected Thai patientsAvihingsanon, A / Apornpong, T / Kerr, SJ / Ananworanich, J / Ruxrungtham, K et al. | 2010
- P61
-
Immune impairment and adaptive response in relation to antiretroviral therapy of HIV‐infectionKaminskiy, GD / Pronin, AJ et al. | 2010
- P62
-
Role of platelet activation in the cardiovascular complications associated with HIV infection: differential effect of abacavir versus tenofovirFrancisci, D / Falcinelli, E / Belfiori, B / Petito, E / Mezzasoma, M / Baldelli, F / Gresele, P et al. | 2010
- P63
-
Platelet activity in HIV‐infected patients on abacavir‐containing antiretroviral therapyPalacios, R / González‐Correa, JA / Ruiz, J / Nuño, E / Márquez, M / de la Cruz, JP / Santos, J et al. | 2010
- P64
-
Cardiovascular risk in patients visiting the Hadassah AIDS Center, JerusalemSchulman, S / Rotshild, V / Pops, K Olshtein / Korem, M / Israel, S / Hauzi, M / Maayan, S et al. | 2010
- P65
-
Incidence of ischemic cardiovascular events in the maraviroc clinical development programPortsmouth, S / Burnside, R / Lazzarin, A / Johnson, M / Valdez, H et al. | 2010
- P66
-
Low serum phosphate levels are related to increased cardiovascular risk in HIV‐1 infected patientsGrima, P / Guido, M / Chiavaroli, R / Tundo, P / Zizza, A et al. | 2010
- P67
-
Prevalence of cardiovascular risk factors in Spanish HIV‐1‐infected male inmatesGolf, JP / Sala, L / Aramburo, J / Sardà, P / Perez‐Alvarez, N / Llibre, JM et al. | 2010
- P68
-
Nitric oxide protects against HIV gp120 endothelial injuryFiorucci, S / Mencarelli, A / Francisci, D / Distrutti, E / Renga, B / Baldelli, F et al. | 2010
- P69
-
Higher red blood cell distribution width is associated with a worse virologic and clinical situation in HIV‐infected patientsPuerta, S / Gallego, M / Palacios, R / Ruiz, J / Nuño, E / Márquez, M / Santos, J et al. | 2010
- P70
-
Alexithymia, an impairment of emotional cognitive processing, is a candidate risk factor for carotid artery plaque formation in HIV‐infected patientsVadini, F / Sozio, F / Mazzotta, E / Agostinone, C / Ursini, T / Agostinone, A / Placido, G / Manzoli, LM / Parruti, G et al. | 2010
- P71
-
Lipodystrophy and metabolic syndrome in Romanian HIV‐infected adultsArbune, M et al. | 2010
- P72
-
Mesenteric fat thickness in a group of HIV patients on HAARTLee, SS / Liu, E / To, KW et al. | 2010
- P73
-
Hypertriglyceridemic waist identifies HIV+ men and women at increased cardiometabolic riskGuaraldi, G / Zona, S / Orlando, G / Carli, F / Stentarelli, C / Despres, J / Ross, R et al. | 2010
- P74
-
Metabolic: week 48 comparison of metabolic parameters and biomarkers in subjects receiving darunavir/ritonavir or atazanavir/ritonavirOverton, T / Aberg, JA / Gupta, S / Ryan, R / Baugh, B / De La Rosa, G et al. | 2010
- P75
-
Adiponectin and leptin levels in HIV‐infected patients with lipodystrophy in Southern IndiaJacob, S Mini / Phoebe, K Annie / Hemalatha, R / Sivakumar, MR / Ravindran, MP / Natarajan, MV et al. | 2010
- P76
-
Nutritional status in HIV‐infected patients using Changi's mini nutritional assessmentCervero, M / Alcázar, V / Sanz, R / García‐La Calle, C / Agud, JL et al. | 2010
- P77
-
Dietician‐based approach to lipodystrophic syndrome: role of bioelectrical impedance analysis at week 12Orofino, G / Guastavigna, M / Martinoglio, P / Penoncelli, D / Demarie, D / Tettoni, M / Desiderato, P / Di Frenna, R / Zignin, C et al. | 2010
- P78
-
Altered phosphate metabolism in HIV‐1‐infected patients: another feature of metabolic syndrome?Grima, P / Zizza, A / Guido, M / Calabrese, P / Chiavaroli, R / Sodo, MR / Tana, M / Tundo, P et al. | 2010
- P79
-
Switching to nevirapine (NVP) significantly increases high‐density lipoprotein cholesterol (HDL‐C) in treatment‐experienced patients (NEVICOR study)Rodriguez, JM / Delgado, M / Viciana, P / Lopez‐Ruz, MA / Leal, M / Alcacer, F / Deig, E / Antela, A / Pedrol, E / Moreno, S et al. | 2010
- P80
-
Switching from Kivexa + efavirenz to Atripla reduces total cholesterol in hypercholesterolemic subjects: final results of a 24‐week, randomized studyMoyle, G / Orkin, C / Fisher, M / Anderson, J / Dhar, J / Wang, MH / Ewan, J et al. | 2010
- P81
-
CD4 response, lipid changes and liver outcome in 506 patients receiving nevirapine‐based regimens for a median of 9 yearsPodzamczer, D / Tiraboschi, JM / Mallolas, J / Cárdenes, MA / Casas, E / Castro, A / Echevarria, S / Leal, M / Bernanldo de Quirós, JC Lopez / Moreno, S et al. | 2010
- P82
-
Chronic kidney disease in patients with normal eGFR at baseline: results from EuroSIDARyom, L / Mocroft, A / Reiss, P / Ledergerber, B / De Wit, S / Duiculescu, D / Monforte, AD / Murphy, M / Lundgren, JD / Kirk, O et al. | 2010
- P83
-
Kidney tubular function and serum phosphate levels in HIV‐1‐infected patients treated with tenofovir: preliminary resultsGrima, P / Zizza, A / Calabrese, P / Chiavaroli, R / Faraone, A / Tana, M / Sodo, MR / Tundo, P / Guido, M et al. | 2010
- P84
-
Smoking, female gender and PI use are associated with decreasing renal function in TDF‐containing HAARTUglietti, A / Gervasoni, C / Gabrielli, E / Di Giambenedetto, S / Cauda, R / Esposito, R / Grima, P / Di Perri, G / Maserati, R / Galli, M et al. | 2010
- P85
-
A magnifying glass onto renal function and serum lipid evolutions after tenofovir (TDF) and emtricitabine (FTC) in combination with atazanavir/ritonavir (ATV/r) versus efavirenz (EFV) as first‐line HAART (the INCA trial)Izzo, I / Albini, L / Calabresi, A / Motta, D / Bellagamba, R / Fezza, R / Narciso, P / Sighinolfi, L / Maggi, P / Focà, E et al. | 2010
- P86
-
The 10 year safety and efficacy of tenofovir disoproxil fumarate (TDF)‐containing once‐daily highly active antiretroviral therapy (HAART)Cassetti, I / Etzel, A / Madruga, JV / Suleiman, JM / Zhou, Y / Rhee, M / Warren, DR et al. | 2010
- P87
-
Intracellular tenofovir‐diphosphate accumulation in an HIV‐infected patient with Fanconi syndrome and osteomalaciaHaverkort, ME / van der Spek, BW / Lips, PT / Slieker, WAT / Bronsveld, W et al. | 2010
- P88
-
The association between metabolic syndrome and the occurrence of nephrolithiasis in HIV‐infected patientsDumitru, IM / Rugina, S / Sotila, G / Dumitru, E / Rugina, CN et al. | 2010
- P89
-
Prevalence of chronic renal failure stage 3 or more in HIV‐infected patients in Antwerp: an observational studyColson, AW / Florence, E / Augustijn, H / Verpooten, GA / Lynen, L / Gheuens, E et al. | 2010
- P90
-
Hepatotoxicity in patients co‐infected with HIV and tuberculosis while receiving NNRTI‐based antiretroviral regimen and rifampicinMankhatitham, W / Lueangniyomkul, A / Manosuthi, W et al. | 2010
- P91
-
Liver safety of two nucleoside analogs plus efavirenz, nevirapine or a ritonavir‐boosted protease inhibitor in HIV/HCV‐coinfected drug‐naïve patientsMacías, J / Mallolas, J / López‐Cortés, LF / Cartón, JA / Domingo, P / Moreno, S / Iribarren, JA / Neukam, K / Rodrigo, A / Jiménez‐Expósito, MJ et al. | 2010
- P92
-
Liver fibrosis: concordance analysis between APRI and FIB‐4 scores, evolution and predictors in a cohort of HIV patients without HCV and HBV infectionMendeni, M / Focà, E / Gotti, D / Ladisa, N / Quiros‐Roldan, E / Vavassori, A / Castelnuovo, F / Carosi, G / Angarano, G / Torti, C et al. | 2010
- P93
-
Clinical significance of hyperbilirubinemia in the CASTLE studyUy, J / Hu, W / Wirtz, V / Hosey, T / Butcher, D / McGrath, D / Farajallah, A et al. | 2010
- P94
-
A case of nodular regenerative hyperplasia in a patient who had been taking didanosineJackson, C / Fox, R / Priest, M / Clutterbuck, D / Peters, E et al. | 2010
- P95
-
Toxic intracellular anabolite levels of tenofovir and didanosine causing a steep CD4‐cell declinede Jong, E / Haverkort, ME / ter Heine, R / Jansen, RS / Beijnen, JH / van Agtmael, MA et al. | 2010
- P96
-
Lack of association between mitochondrial DNA polymorphisms and didexoxynucleoside‐induced hyperlactataemia in black‐African, HIV‐1‐infected patientsArenas‐Pinto, A / Weller, I / Ekong, R / Grant, A / Karstaedt, A / Telisinghe, L / Bolhaar, M / Charalambous, S / Bradman, N / Ingram, C et al. | 2010
- P97
-
Markers of bone turnover are elevated in patients on antiretrovirals independent of the substance usedPiso, RJ / Rothen, M / Rothen, JP / Stahl, M et al. | 2010
- P98
-
Quantitative ultrasound (QUS) in HIV‐infected patients: a reliable and low‐cost technique for bone health assessmentMarocco, R / Martini, H / Belvisi, V / Tieghi, T / Cesareo, R / Del Borgo, C / Lichtner, M / Mastroianni, CM et al. | 2010
- P99
-
Fracture risk in HIV and the need for guidelines: the Probono‐1 TrialPeters, B / Isohanni, H / Tillet, S / Ibrahim, F / Hampson, G / Williams, FMK / Perry, MEO / Duncan, A / Wierzbicki, A et al. | 2010
- P100
-
Rates of bone fractures in a cohort of HIV‐infected adults in the UKSamarawickrama, A / Malik, R / Fisher, M / Gilleece, Y / Walker‐Bone, K et al. | 2010
- P101
-
Prevalence of vitamin D deficiency: cross‐sectional study of a hospital cohort of HIV‐1 infected outpatientsCervero, M / Alcázar, V / García‐La Calle, C / Sanz, R / Agud, JL et al. | 2010
- P102
-
The serum level of 25‐OH vitamin D and Th1 cytokine pattern in HIV infection versus hepatitis C virus infection and hepatitis B virus infectionIacob, SA / Banica, D / Panaitescu, E / Cojocaru, M / Iacob, D et al. | 2010
- P103
-
Prevalence and factors associated with severe vitamin D deficiency in HIV/hepatitis C co‐infected patientsSurah, S / Samarawickrama, A / Campbell, L / Kulasegaram, R / Post, F / Fisher, M / Peters, B / Fox, J et al. | 2010
- P104
-
Tenofovir use is associated with low vitamin D levels in a Spanish HIV cohortCervero, M / García Lacalle, C / Agud, JL / Perea, R Torres / García‐Benaya, E / Jusdado, J / Pons, C Pérez / del Álamo, M et al. | 2010
- P105
-
Safety and efficacy of maraviroc (MVC) combined with multiple different therapeutic agents in highly treatment‐experienced (TE) patients in BrazilFurtado, JJD / Madruga, JV / Bicudo, EL / Eira, M / Lopes, MIB / Netto, EM / de Oliveira, MS / Leite, OHM / Machado, AA / Tupinambas, U et al. | 2010
- P106
-
Behaviour and attitudes in HIV (BEAHIV): a national survey study to examine the level of agreement between physicians and patients in symptom reportingRachlis, A / Gill, J / Harris, M / Macleod, J / Worthington, C / Brunetta, J / Tsang, A / Hew, H / Leith, J / Camacho, F et al. | 2010
- P107
-
Continuing burden of HIV late presenters in the North East of England 2009Premchand, N / Golds, K / Tan, PY / Bittiner, I / Sanker, N / Ong, ELC et al. | 2010
- P108
-
Drug interactions in the elderly HIV‐infected patientCoroiu, C / Tollinchi, F / Hittinger, G / Mokhtari, S / Granet, P / Faucher‐Zaegel, O / Madrid, A / Menard, A / Mattei, JL / Chadapaud, S et al. | 2010
- P109
-
Sexual dysfunction and anxiety in HIV‐1‐infected males in Eastern SicilyCelesia, BM / Coco, C / Bisicchia, F / Pellicanò, G / Mughini, MT / Palermo, F / Nunnari, G / Russo, R et al. | 2010
- P110
-
Raltegravir‐induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: implications for clinical practice and patient safetyPerry, MEO / Almaani, N / Desai, N / Fox, J / Larbalestier, N / Chilton, D et al. | 2010
- P111
-
Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: results from a multicenter studyMadeddu, G / Soddu, V / Ricci, E / Quirino, T / Menzaghi, B / Bellacosa, C / Grosso, C / Melzi, S / Valsecchi, L / Franzetti, M et al. | 2010
- P112
-
Efavirenz use and contraceptive methods in HIV‐positive women in a large urban cohortSeaton, RA / Fox, R / MacConnachie, A / Anderson, P / Nandwani, R / Peters, E / Winter, A / Taylor, R et al. | 2010
- P113
-
Assessing the risk of birth defects associated with atazanavir exposure in pregnancyEsker, S / Albano, J / Tilson, H / Uy, J / Arikan, D / Krantz, K / Jiménez‐Expósito, MJ / Seekins, D et al. | 2010
- P114
-
Administration of darunavir tablets in patients with difficulties in swallowing – two case reportsScholten, S / Mauruschat, S / Hindermann, S / Ranneberg, B et al. | 2010
- P115
-
Evaluating pharmacist involvement in HIV outpatient clinics: can medication histories, drug interaction checks and adherence assessments add benefit?Seden, K / Back, DJ / Khoo, SH et al. | 2010
- P116
-
Adherence, quality of life and number of daily pills in a large cross‐sectional studyGianotti, N / Galli, L / Bocchiola, B / Cahua, T / Panzini, P / Zandonà, D / Salpietro, S / Maillard, M / Danise, A / Pazzi, A et al. | 2010
- P117
-
Changing HIV guidelines: how to communicate treatment startFehr, J / Nicca, D / Langewitz, W / Haerry, D / Battegay, M et al. | 2010
- P118
-
Relating protease inhibitor resistance at time of virological failure with drug exposureVan Luin, M / Bannister, WP / Paredes, R / Phillips, AN / Bruun, J / Van Lunzen, J / Kirk, O / d'Arminio Monforte, A / Cozzi‐Lepri, A / Burger, DM et al. | 2010
- P120
-
Does feedback of medication execution using MEMS caps aid adherence to HAART?: the MEMRI study (MEMS as Realistic Intervention)Davies, S / Asghar, S / Cooper, V / Lange, A / Robertson, C / Vrijens, B / White, DJ et al. | 2010
- P121
-
Antiretroviral regimen complexity as a predictor of adherenceBoyle, C / Wilson, A / Treacy, G / Sheehan, G / Lambert, J / Meegan, C / Mallon, P et al. | 2010
- P122
-
Naïve patients receiving TDF/FTC‐EFV as 2 pills are more likely to modify regimen components than patients receiving a TDF/FTC/EFV single pillPerez‐Valero, I / Martin, N / Valiente, B San Jose / Bernardino‐Serna, JI / Mora, M / Gaya, F / Gonzalez, J / Zamora, FX / Pena, JM / Arribas, JR et al. | 2010
- P123
-
High level of adherence to HAART among refugees and internally displaced persons on HAART in western equatorial region of Southern SudanSalami, O / Buzu, A / Nzeme, C et al. | 2010
- P124
-
Identifying causes of loss to follow up in newly diagnosed HIV‐infected patientsFridman, V / Bello, NS / Lasala, MB et al. | 2010
- P125
-
Transmitted drug resistance associated with transmission clusters in newly diagnosed antiretroviral‐naïve patients in Northern GreeceSkoura, L / Metallidis, S / Buckton, AJ / Mbisa, JL / Pilalas, D / Papadimitriou, E / Papoutsi, A / Haidich, AB / Valagouti, D / Tsachouridou, O et al. | 2010
- P126
-
Analysis of transmitted drug resistance, resistance mutations and future antiretroviral efficacy in HIV‐1 subtype F infected‐patients prior to therapyManolescu, LSC / Sultana, CM / Vagu, C / Temereanca, A / Ruta, SM et al. | 2010
- P127
-
Detection of HIV type 1 mutations on the pol region in untreated patients in Northern Vietnam: determination of drug resistance and subtypesRanger‐Rogez, S / Al Jawhari, M / Nguyen, B / Pham Hong, N / Tran Quoc, T / Pascual, J / Doll, J / Harzic, M / Viretto, G / Weinbreck, P et al. | 2010
- P128
-
Population and ultra‐deep sequencing for tropism determination are correlated with Trofile ES: genotypic re‐analysis of the A4001078 maraviroc studyPortsmouth, S / Valluri, S / Daeumer, M / Thiele, B / Valdez, H / Lewis, M / Craig, C / Thielen, A / James, I / Demarest, J et al. | 2010
- P129
-
Clinical application of genotypic co‐receptor tropism testing from viral RNA and proviral DNA: week 24 analysis of the Berlin maraviroc cohortObermeier, MJ / Carganico, A / Dupke, S / Schranz, D / Cordes, C / Freiwald, M / Klausen, G / Köppe, S / Schuler, C / Mayr, C et al. | 2010
- P130
-
Analysis of BENCHMRK 1 & 2 using PhenoSense® assay for darunavir (DRV/r) resistance and exploration of functional monotherapy with RAL vs DRVRockstroh, J / Eron, J / Cooper, D / Steigbigel, R / Nguyen, BY / Xu, X / Wan, H / Rodgers, A / Miller, M / Leavitt, R et al. | 2010
- P131
-
Analysis of major and minor IAS‐USA PI mutations in the MONET trial of darunavir/ritonavir monotherapy versus DRV/r + 2NRTIsPulido, F / Arribas, JR / Hill, A / van Delft, Y / Moecklinghoff, C et al. | 2010
- P132
-
Changing prevalence of darunavir resistance‐associated mutations (DRV RAMs) in clinical samples received for routine resistance testing: 2003‐2009De La Rosa, G / Pattery, T / Picchio, G / Lathouwers, E / Villacian, J / Van der Borght, K et al. | 2010
- P133
-
Darunavir resistance spectrum in darunavir‐naᵢve patients harboring virological failure to antiretroviral therapyMarcelin, AG / Charpentier, C / Wirden, M / Descamps, D / Calvez, V et al. | 2010
- P134
-
Resistance after viral failure on atazanavir‐containing therapy: multinational clinical cohort (BMS AI424‐128 — ‘IMPACT’) final analysisZolopa, A / Towner, W / Lazzarin, A / Fätkenheuer, G / Butcher, D / Uy, J et al. | 2010
- P135
-
High levels of polymorphisms related to raltegravir resistance among raltegravir‐naïve individuals in BrazilPena, N Mantovani / Azevedo, R Gonçalves / Castro, D Funayama / Diaz, R Sobhie / Komninakis, S Vasconcelos et al. | 2010
- P136
-
Prevalence of resistance and HIV‐1 protease mutation patterns after failures with fosamprenavir‐containing regimensMarcelin, AG / Charpentier, C / Ferreira, C / Wirden, M / Lemarchand, C / Descamps, D / Calvez, V et al. | 2010
- P138
-
Is extended resistance to the historical antiretroviral drugs & drug classes still a risk factor for HIV progression?Zaccarelli, M / Lorenzini, P / Marconi, P / Forbici, F / Gori, C / Sette, P / Ceccherini‐Silberstein, F / Narciso, P / Perno, CF / Antinori, A et al. | 2010
- P139
-
Prevalence of HIV drug‐resistance mutations in HIV‐infected Mexican patients heavily experienced to antiretroviral therapyGaytán‐Martínez, JE / Mata‐Marín, JA / Gutierrez‐Escolano, F / Pérez‐Saleme, L / Treviño‐Pérez, S / Vázquez‐Rosales, JG / Matías‐Juan, N / Díaz‐Ramos, RD / Arias‐Flores, R et al. | 2010
- P140
-
HIV drug resistance in children with treatment failure to first‐line regimens in Ho Chi Minh City, VietnamNhung, VTT / Colby, D / Khanh, TH / Viet, TT / Lu, D / Thuy, HT / An, B / Giang, LT et al. | 2010
- P141
-
Molecular epidemiology of antiretroviral resistance in therapy‐experienced HIV‐1 patients in Cuba (2009)Pérez, L / Aleman, J / Correa, C / Pérez, J / Fonseca, C / Aragones, C / Pérez, D / Alvarez, A / Vandamme, AM / Kourí, V et al. | 2010
- P142
-
Development of drug resistance among HIV‐1 F1 sub‐type patients with treatment failureTemereanca, A / Sultana, CM / Manolescu, L / Vagu, C / Grancea, C / Ruta, S et al. | 2010
- P143
-
Pro‐viral DNA and antiretroviral treatment simplificationZucman, D / Rouzioux, C / Avettand‐Fenoel, V et al. | 2010
- P144
-
Haemoglobin and anaemia in the SMART studyMocroft, A / Lifson, AR / Touloumi, G / Neuhaus, J / Fox, Z / Palfreeman, A / Vjecha, M / Hodder, S / De Wit, S / Lundgren, JD et al. | 2010
- P145
-
Genotype testing in HIV‐infected pregnant womenAfonso, C / Zagalo, A / Janeiro, N / Antunes, F et al. | 2010
- P146
-
High prevalence of the UGT1A1*28 variant in HIV‐infected individuals in GreecePanagopoulos, P / Paraskevis, D / Sypsa, V / Detsika, M / Protopapas, K / Sakka, V / Poulakou, G / Papadopoulos, A / Petrikkos, G / Hatzakis, A et al. | 2010
- P147
-
Feasibility of testing antibodies to HIV from filter paper using HIV rapid test kitsGanesan, A / Thatchinamoorthy, G / Saramini, S et al. | 2010
- P148
-
Effect of lipemia and bilirubinemia on HIV‐1 protease and reverse transcriptase genotyping and phenotyping success: a five‐year analysisPattery, T / Van Cauwenberge, A / Van Hove, M / Smits, V / Van Soom, K / Villacian, J et al. | 2010
- P149
-
Development of a single‐tube, low‐cost, analytical process to extract, separate and determine efavirenz and rifampicin plasma concentrations in HIV/TB co‐infected patientsFox, D / O’Connor, R / Mallon, P / McMahon, G et al. | 2010
- P150
-
Lack of utility of phosphate serum monitoring in HIV‐infected patients on a tenofovir‐based antiretroviral regimenWikman, P / Safont, P / Perez‐Elías, MJ / Moreno, A / Dronda, F / Moreno, S / Casado, JL et al. | 2010
- P151
-
CCR5 D32 modifies 15‐year mortality risk associated with well‐established clinical and immunological factors among HIV‐infected patientsParczewski, M / Leszczyszyn‐Pynka, M / Bander, D / Urbañska, A / Kaczmarczyk, M / Ciechanowicz, S / Boron‐Kaczmarska, A et al. | 2010
- P152
-
What drives a normal relation between T‐CD4 and T‐CD8?Badura, R / Antunes, RJG / Janeiro, N / Afonso, C / Antunes, F et al. | 2010
- P153
-
Comparative evaluation of ARV therapy efficiency among patients at the Kiev regional AIDS centerYurchenko, YO / Stepchenkova, T / Karnets, KI / Martinenko, MO et al. | 2010
- P154
-
Feasibility and effectiveness of combination antiretroviral therapy in HIV‐infected infants in Pietermaritzburg, South AfricaVan der Linden, D / Purchase, S / McKerrow, NH et al. | 2010
- P155
-
Promoting presumptive diagnosis of severe HIV disease to increase uptake of antiretroviral therapy in HIV‐infected infantsChiwoko, J / Mhango, E / Phiri, S / Weigel, R et al. | 2010
- P156
-
Audit of outcomes of early initiation of antiretroviral therapy in children admitted to the paediatric wards at Kilifi district hospital, KenyaNabwera, HM / Mwaringa, S / Kimutai, R / Berkley, JA et al. | 2010
- P157
-
Salvage therapy with raltegravir in a 3‐month‐old infantBrolund, AB / Ilchmann, C / Ganschow, R / Degen, O et al. | 2010
- P158
-
High preterm delivery rates associated with initiation of HAART during pregnancyTaylor, GP / Douglas, M / Smith, J et al. | 2010
- P159
-
Minority M184V variants in women exposed to 3TC/FTC‐containing lopinavir‐ritonavir (LPVr) regimens in pregnancySurah, S / Oshea, S / Costelloe, S / Hanlon, M / Mullen, J / Chrystie, I / Taylor, GP / De Ruiter, A et al. | 2010
- P160
-
Antiretroviral strategies for the treatment of pregnant HIV+ women and prevention of perinatal HIV transmission in Dodoma, Tanzania: AMANI StudyLiuzzi, G / Vairo, F / Chaula, Z / Nguhuni, B / Nicastri, E / Bevilacqua, N / Cannas, A / Paglia, MG / Ippolito, G et al. | 2010
- P161
-
Use of antiretroviral therapy during pregnancy among HIV‐infected women attending an urban care centreSsewankambo, F / Nalugwa, C / Sempa, J / Walusimbi, J / Kambugu, A et al. | 2010
- P162
-
A complex of measures effectiveness in reducing mother‐to‐child HIV transmissionMinaeva, SV / Moshkovich, GF et al. | 2010
- P163
-
Amniocentesis is a low‐risk procedure in HIV‐treated pregnant womenSimoes, MM / Marques, CO / Albergaria, F / Guerreiro, C / Pereira, A / Correia, J / Castela, J et al. | 2010
- P164
-
Pregnancy decisions and contraceptive use among HIV‐positive women: a study in a large urban clinic in sub‐Saharan AfricaWalusimbi, J / Birabwa, E / Nabankema, E / AnneMarie, A / Lutalo, I / Nakiwooga, A et al. | 2010
- P165
-
A method to estimate the number of people in a country or region with HIV who are undiagnosed and in need of ARTLodwick, RK / Sabin, CA / Phillips, AN et al. | 2010
- P166
-
BEST: Better Equipped to Start TreatmentBennett, J et al. | 2010
- P167
-
Older HIV‐infected individuals present late and have a higher mortality: a UK clinic cohort studyIwuji, CC / Pao, D / Gilleece, Y / Fisher, M / Churchill, D et al. | 2010
- P168
-
Offering HIV testing in an emergency admission unit in Newcastle upon Tyne, UK — a pilot audit studyEllis, S / Graham, L / Price, DA / Ong, ELC et al. | 2010
- P169
-
A high occurrence of late presenters and missed HIV diagnosis in clinical care in SwedenBrännström, J / Svedhem, V / Yilmaz, A / Blaxhult, A / Wendahl, S / Sönnerborg, A et al. | 2010
- P170
-
Audit of telephone HIV clinics: effective and acceptableWoolley, WFC / Babu, C / Sukthankar, A / McQuillan, O et al. | 2010
- P171
-
Newly diagnosed HIV patients in Lima, Peru: a comparison of individuals diagnosed through an intervention program versus self‐referred individualsHidalgo, JA / Castillo, N / Agurto, C et al. | 2010
- P172
-
Adherence to HIV treatment guidelines for initiation of antiretroviral therapy in AustraliaBloch, M / Hoy, J / Cunningham, N / Roth, N / Andrianopoulos, N / Rayner, C / Carr, A et al. | 2010
- P173
-
Five‐year outcomes of HAART at a non‐governmental treatment center in Lima, PeruCastillo, N / Agurto, C / Benites, C / Hidalgo, JA et al. | 2010
- P174
-
The impact of late presentation: analysis of a cohort of 313 Portuguese patientsAlfaiate, D / Miranda, AC / Rijo, J / Fernandes, D / Borges, F / Farinha, H / Mansinho, K et al. | 2010
- P175
-
T‐CD4+ cell count at the date of the HIV diagnosisDomingues da Silva, AR / Mendez, J / e Castro, R Sarmento et al. | 2010
- P176
-
Pharmacokinetics of lamivudine, abacavir and zidovudine administered twice daily as syrups versus scored tablets in HIV‐1‐infected Ugandan childrenGitta, PK / Kendall, L / Musiime, V / Adkison, K / Kekitiinwa, AA / Ferrier, A / Opilo, O / Lou, Y / Bwakura‐Dangarembi, MF / Nahirya‐Ntege, P et al. | 2010
- P177
-
Therapeutic drug monitoring (TDM) of atazanavir in pregnancyElse, LJ / Jackson, V / Brennan, M / Breiden, J / Weldridge, C / Coulter‐Smith, S / Back, DJ / Khoo, SH / Lambert, J et al. | 2010
- P178
-
SLCO3A1 expression is a major determinant of atazanavir PBMC penetration in HIV‐infected patientsSiccardi, M / D'Avolio, A / Baietto, L / Simiele, M / Bonora, S / Back, DJ / Di Perri, G / Owen, A et al. | 2010
- P179
-
A filter‐based cross‐sectional analysis of an HIV‐positive, HAART‐treated cohort in rural Burundi: pharmacokinetics, pharmacogenetics and viral loadCalcagno, A / Milia, MG / D'Avolio, A / Ndayishimiyae, P / Dusabimana, P / Bonora, S / Cusato, J / Simiele, M / Rostagno, R / Siccardi, M et al. | 2010
- P180
-
Pharmacokinetics of plasma lopinavir/ritonavir following the administration of 400/100, 200/150, and 200/50 mg twice daily in HIV‐negative volunteersJackson, AGA / Hill, A / Else, LJ / Back, DJ / Morley, R / Puls, R / Amin, J / Lin, E / Boffito, M et al. | 2010
- P181
-
Population pharmacokinetic and pharmacogenetic analysis of nevirapine in hypersensitive and tolerant HIV‐infected patients from MalawiDickinson, L / Chaponda, M / Carr, D / van Oosterhout, JJ / Kumwenda, J / Lalloo, DG / Pirmohamed, M / Heyderman, R / Khoo, SH et al. | 2010
- P182
-
PK/PD modeling supports the dose‐escalation decision in VIKINGLovern, M / Underwood, M / Nichols, G / Song, I et al. | 2010
- P183
-
Impact of CYP2B6 and CYP2A6 polymorphisms on efavirenz plasma concentrations in Ghanaian HIV‐infected patientsZhang, Y / Owen, A / Egan, D / Sarfo, SF et al. | 2010
- P184
-
Population pharmacokinetic modelling of once‐daily ritonavir‐boosted darunavir in HIV‐infected patientsDickinson, L / Jackson, AGA / Garvey, LJ / Watson, V / Khoo, SH / Winston, A / Boffito, M / Davies, GR / Back, DJ et al. | 2010
- P185
-
Pharmacokinetic (PK) and pharmacodynamic analyses of once‐ and twice‐daily darunavir/ritonavir (DRV/r) in the ODIN trialSekar, V / De La Rosa, G / Van de Casteele, T / Spinosa‐Guzman, S / Vis, P / Hoetelmans, RMW et al. | 2010
- P186
-
Effect of intrinsic and extrinsic factors on the pharmacokinetics of TMC278 in antiretroviral‐naïve, HIV‐1‐infected patients in ECHO and THRIVECrauwels, HM / van Schaick, E / van Heeswijk, RPG / Vanveggel, S / Boven, K / Vis, P et al. | 2010
- P187
-
Herb‐drug interaction between Echinacea purpurea and darunavir/ritonavir in HIV‐infected patientsMoltó, J / Valle, M / Miranda, C / Cedeño, S / Negredo, E / Barbanoj, MJ / Clotet, B et al. | 2010
- P188
-
Moringa oleifera supplementation by patients on antiretroviral therapyMonera, TG / Maponga, CC et al. | 2010
- P189
-
The use of a darunavir/ritonavir once‐daily regimen in two pregnant womenLambert, JS / Else, LJ / Jackson, V / Dickinson, L / Back, DJ / Brennan, M / Weldridge, C / Coulter‐Smith, S / Gibbons, S / Khoo, SH et al. | 2010
- P190
-
Treatment of chronic invasive fungal sinusitis with voriconazole in an HIV patientHo, A / McGarry, G / Peters, E et al. | 2010
- P191
-
Opportunistic infections (OIs) present in HIV‐seropositive patients: a studyRamaiah, K Ayodhya / Sudha Rani, B / Anand, R / Ramola, S / Satish Babu, P / Ramesh Babu, R et al. | 2010
- P192
-
Immunological diagnosis of CMV infection in HIV‐infected patientsDumitru, IM / Rugina, S / Dumitru, E / Cernat, RC / Diaconu, S / Mitroi, C Maxim et al. | 2010
- P193
-
Epidemiology of HIV‐associated tuberculosis (TB) co‐infection in Krasnoyarsk region, Russian FederationChaychuk, TA / Gankina, NU / Nikonova, OG et al. | 2010
- P194
-
A minority of tuberculosis cases occurring during HIV care is possibly preventableSkeie, L / Skrede, T / Maeland, A et al. | 2010
- P195
-
Generalized tuberculosis in HIV‐infected patients with AIDSZimina, VN / Vasilieva, IA / Kravchenko, AV / Batyrov, FA et al. | 2010
- P196
-
Therapy of the patients with HIV/TB infection and dynamics of level ‘naïve’ CD4‐lymphocytesPopova, AA / Kravchenko, AV / Kozhevnikova, GM / Serebrovskaya, LV et al. | 2010
- P197
-
Enfuvirtide in therapy at patients with HIV‐infection and tuberculosisKravchenko, AV / Kuznetsova, AV / Kozyrev, OA / Lukyanova, VA / Kanestri, VG et al. | 2010
- P198
-
Sudden unexplained death in a patient with HIV and MDR‐TBBoxall, E / Milne, J / Peters, E / Sykes, C et al. | 2010
- P199
-
Hepatitis C virus (HCV) infection and re‐infection among HCV‐ and HIV/HCV‐infected injection drug usersConway, B / Barrieshee, A / Tossonian, HK / Wight, K / Jassemi, S / Tong, M / Knight, E / Gallagher, L / Duncan, F / DeVlaming, S et al. | 2010
- P200
-
Increasing numbers of acute hepatitis C infections in HIV‐infected MSM and high reinfection rates following SVRStellbrink, HJ / Schewe, CK / Vogel, M / Noah, C et al. | 2010
- P201
-
High prevalence of genotype G in HIV co‐infected patients compared with HBV monoinfected patients in MéxicoMata‐Marín, JA / Gaytán‐Martínez, JE / Arroyo‐Anduiza, CI / Calderón‐Rodriguez, G et al. | 2010
- P202
-
Acute hepatitis C in persons infected with the human immunodeficiency virus (HIV): the ‘real‐life setting’ proves the conceptIngiliz, P / Obermeier, MJ / Weitner, L / Cordes, C / Moll, A / Hintsche, B / Schlote, F / Köppe, S / Mayr, C / Baumgarten, A et al. | 2010
- P203
-
Correlates of hepatic stiffness by FibroScan© in a multicentric Italian cohort of HIV‐infected patientsTarquini, P / Sozio, F / Marchionni, E / Gabrielli, E / Polilli, E / Ancarani, F / Di Giammartino, D / Manzoli, LM / Parruti, G et al. | 2010
- P204
-
Role of HCV infection in the development of carotid atherosclerosis in a cohort of HIV‐infected patientsFerrara, S / Tartaglia, A / Santantonio, T / Grisorio, B et al. | 2010
- P205
-
Do interleukin‐28B single nucleotide polymorphisms influence the natural history of chronic hepatitis B?Martín‐Carbonero, L / Rallón, NI / Benito, JM / Poveda, E / González‐Lahoz, J / Soriano, V et al. | 2010
- P206
-
No impact of IL28B polymorphisms on liver enzymes in patients coinfected with HIV and HCVFernández‐Montero, JV / Martín‐Carbonero, L / Barreiro, P / Rallón, NI / Benito, JM / González‐Lahoz, J / Soriano, V et al. | 2010
- P207
-
Effectiveness of pegylated interferon alfa plus HAART in HIV/HBV treatment‐naïve coinfected patientsMata‐Marín, JA / Arroyo‐Anduiza, CI / Arias‐Flores, R / Gaytán‐Martínez, JE et al. | 2010
- P208
-
Sustained virological response in HIV/HCV co‐infected patients without rapid virological response (RVR) on peginterferon‐ribavirin therapyLabarga, P / Vispo, ME / Guardiola, JM / Miralles, C / Martín‐Carbonero, L / Portu, J / Barreiro, P / Miralles, P / Morello, J / Tellez, MJ et al. | 2010
- P209
-
Efficacy and safety of therapy of chronic hepatitis B with telbivudine (LdT) in patients with HIV‐infection without HAARTTsarenko, SP / Kravchenko, AV / Kanestri, VG / Maximov, SL et al. | 2010
- P210
-
Efficacy and safety of TMC278 in treatment‐naïve, HIV‐1‐infected patients with HBV/HCV co‐infection enrolled in the phase III ECHO and THRIVE trialsNelson, M / Amaya, G / Clumeck, N / Arns Da Cunha, C / Jayaweera, D / Junod, P / Taisheng, L / Tebas, P / Stevens, M / Buelens, A et al. | 2010
- P211
-
Response to treatment of hepatitis C in HCV/HIV co‐infected patients is not influenced by either abacavir or tenofovir with weight‐based ribavirinBhatti, L / Shah, S / Khanlou, H et al. | 2010
- P212
-
Efficiency of HIV‐1 PR‐RT genotyping is not impacted by co‐infection with HCVDeloof, ACA / De Wolf, H / Verlinden, Y / Villacian, J / Pattery, T et al. | 2010
- P213
-
Relationship between dynamics of Epstein‐Barr virus and immune activation in HIV‐1 infected subjects in the HAART eraCattelan, AM / Zanchetta, M / Sasset, L / Petrara, R / Freguja, R / Gianesin, K / Cecchetto, MG / Cremona, F / De Rossi, A et al. | 2010
- P215
-
Detrimental clinical interaction between ritonavir‐boosted protease inhibitors and vinblastin in HIV‐infected patients with Hodgkin lymphomaCingolani, A / Torti, L / Pinnetti, C / de Gaetano Donati1, K / Murri, R / Tacconelli, E / Larocca, LM / Teofili, L et al. | 2010
- P216
-
Cancer chemotherapy: early experience with combined chemotherapy for HIV‐infected Kaposi's sarcoma patients at Lighthouse clinic, Lilongwe, MalawiMulinde, HF / Tweya, H / Chiwoko, J / Feldacker, C / Phiri, S / Nyirenda, M / Weigel, R / Mlundira, L et al. | 2010
- P217
-
Trends in human papillomavirus (HPV) infection among HIV‐positive women in the pre‐HAART and HAART era in a Nigerian clinicOnigbogi, MO / Ojo, OY et al. | 2010
- P218
-
Review of HIV testing at a district general hospital in an area of high HIV prevalence following the introduction of new national guidelinesPage, ID / Phillips, M / Flegg, P / Palmer, R et al. | 2010
- P219
-
HIV testing in non‐traditional settings: feasibility and acceptability in an acute admissions unitCridford, R / Thornton, A / Rayment, M / Mguni, S / Millett, D / Mandalia, S / Nardone, A / Tenant‐Flowers, M / Sullivan, A / Ghosh, R et al. | 2010
- P220
-
Clinical profile of HIV/AIDS patients admitted to a tertiary outpatient clinic in Istanbul, TurkeyAydin Altuntas, O / Kumbasar Karaosmanoglu, H / Korkusuz, R / Nazlican, O et al. | 2010
- P221
-
Aetiologies and factors associated with mortality among HIV‐infected patients at Taraba State Specialist Hospital, Jalingo, NigeriaDashe, DR et al. | 2010
- P222
-
Causes of death in patients infected with HIV from 1985 to 2008Mendez, J / Sarmento e Castro, R / Domingues da Silva, AR et al. | 2010
- P223
-
Syphilis infection is associated with an increase in plasma viral load in HIV infected patients: results from the FHDH cohort — ANRS CO4Jarzebowski, W / Piketty, C / de Truchis, P / Caumes, E / Farhi, D / Lascaux, AS / Bouldouyre, MA / Derradji, O / Pacanowski, J / Dupin, N et al. | 2010
- P224
-
Low immunogenicity of whole virion, verocell‐derived, inactivated, pandemic influenza H1N1 vaccine in HIV‐infected patientsLagler, H / Grabmeier‐Pfistershammer, K / Touzeau‐Römer, V / Tobudic, S / Rieger, A / Burgmann, H et al. | 2010
- P225
-
No effect of a single supratherapeutic dose of lersivirine, a next‐generation NNRTI, on QTc interval in healthy subjectsVourvahis, M / Wong, R / Ndongo, NM / O'Gorman, M / Tawadrous, M et al. | 2010
- P226
-
Leukocyte extract reduces HIV replication and modulates cellular factors involved in HIV infection: therapeutic meantFernandez‐Ortega, C / Casillas, D / Dubed, M / Navea, L / Ramirez, A / Lopez, L / Paneque, T / Reinoso, Y et al. | 2010
- P227
-
Therapeutics designed to neutralize soluble HIV tat protein could preserve IL‐7 signaling and CD8 T‐cell function in HIV+ patientsFaller, EM / Sugden, SM / MacPherson, PA et al. | 2010
- P228
-
Novel monitoring technique to minimise the risk for patients participating in pilot studies of investigational compoundsCuffe, R / Ait‐Khaled, M / Hughes, S / Min, S / Nichols, G / Thomas, D / Underwood, M / Yeo, JM et al. | 2010
- P230
-
Prevalence of type 2 diabetes mellitus and its predictive factors in Italy: a comparison between HIV‐infected and uninfected subjectsGalli, L / Salpietro, S / Pellicciotta, G / Galliani, A / Piatti, PM / Hasson, H / Guffanti, M / Gianotti, N / Bigoloni, A / Lazzarin, A et al. | 2010
- P231
-
Smoking prevalence, cessation rates and relapse rates in the Swiss HIV Cohort Study (SHCS)Huber, M / Ledergerber, B / Jaccard, R / Elzi, L / Furrer, H / Hirschel, B / Cavassini, M / Bernasconi, E / Schmid, P / Weber, R et al. | 2010
- P232
-
Prevalence and risk factors for chronic obstructive lung disease in HIV‐infected patients in the HAART eraMadeddu, G / Fois, AG / Calia, GM / Becciu, F / Piras, B / Fiori, ML / Spada, V / Lovigu, C / Mannazzu, M / Pirina, P et al. | 2010
- P233
-
High plasma levels of parathyroid hormone (PTH) are associated with an increased cardiovascular risk among HIV‐infected subjectsSpagnuolo, V / Galli, L / Salpietro, S / Vinci, C / Cossarini, F / Travi, G / Rubinacci, A / Mignogna, G / Cernuschi, M / Bossolasco, S et al. | 2010
- P234
-
Cost‐effectiveness of atazanavir‐ritonavir versus lopinavir‐ritonavir in HIV patients initiating first‐line antiretroviral therapyBroder, MS / Juday, T / Uy, J / Chang, EY / Bentley, TGK et al. | 2010
- P235
-
Cost‐efficacy analysis of the MONET trial using Spanish antiretroviral drug pricesArribas, JR / Hill, A / Garcia, I / Anceau, A et al. | 2010
- P236
-
Late versus non‐late presentation of HIV/AIDS: an economic impact analysisGrabmeier‐Pfistershammer, K / Rieger, A / Schroeck, T / Schlag, M et al. | 2010
- P237
-
Cost‐effectiveness of 2NRTI+NNRTI versus 2NRTI+PI as the initial cART regimenAragão, F / Vaz Pinto, I / Vera, J et al. | 2010
- S1
-
An introduction to family‐centred services for children affected by HIV and AIDSRichter, Linda et al. | 2010
- S1
-
5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention: summary of key research and implications for policy and practice ‐ IntroductionKort, Rodney et al. | 2010
- S2
-
Family‐centred approaches to the prevention of mother to child transmission of HIVBetancourt, Theresa S / Abrams, Elaine J / McBain, Ryan / Fawzi, Mary C Smith et al. | 2010
- S2
-
5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention: summary of key research and implications for policy and practice – Basic sciencesMascolinli, Mark / Kort, Rodney et al. | 2010
- S3
-
Lessons learned from family‐centred models of treatment for children living with HIV: current approaches and future directionsLeeper, Sarah C / Montague, Brian T / Friedman, Jennifer F / Flanigan, Timothy P et al. | 2010
- S3
-
5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention: summary of key research and implications for policy and practice – Clinical sciencesMascolinli, Mark / Kort, Rodney et al. | 2010
- S4
-
Fathers and HIV: considerations for familiesSherr, Lorraine et al. | 2010
- S4
-
5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention: summary of key research and implications for policy and practice – Biomedical preventionMascolinli, Mark / Kort, Rodney et al. | 2010
- S5
-
5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention: summary of key research and implications for policy and practice – Operations researchKort, Rodney et al. | 2010
- S5
-
Data availability on men's involvement in families in sub‐Saharan Africa to inform family‐centred programmes for children affected by HIV and AIDSHosegood, Victoria / Madhavan, Sangeetha et al. | 2010
- S6
-
Children of female sex workers and drug users: a review of vulnerability, resilience and family‐centred models of careBeard, Jennifer / Biemba, Godfrey / Brooks, Mohamad I / Costello, Jill / Ommerborn, Mark / Bresnahan, Megan / Flynn, David / Simon, Jonathon L et al. | 2010
- S7
-
The impact of HIV and high‐risk behaviours on the wives of married men who have sex with men and injection drug users: implications for HIV preventionSolomon, Sunil S / Mehta, Shruti H / Latimore, Amanda / Srikrishnan, Aylur K / Celentano, David D et al. | 2010
- S8
-
Family‐based HIV prevention and intervention services for youth living in poverty‐affected contexts: the CHAMP model of collaborative, evidence‐informed programme developmentBhana, Arvin / McKay, Mary M / Mellins, Claude / Petersen, Inge / Bell, Carl et al. | 2010
- S9
-
Family‐centred HIV interventions: lessons from the field of parental depressionTomlinson, Mark et al. | 2010